Startups, like Glooko, are pioneering better diabetes care by enabling easier blood glucose monitoring, integrating health data from devices and apps, and providing actionable insights.

Startups, like Glooko, are pioneering better diabetes care by enabling easier blood glucose monitoring, integrating health data from devices and apps, and providing actionable insights.

Glooko, led by CEO Mike Alvarez, provides a connected care platform that integrates data from over 200 diabetes and health monitoring devices and apps into a single interface, enabling better health outcomes for patients and more effective care by their clinicians.

Monarch Medical Technologies, developer of the EndoTool Glucose Management System, was acquired by Glooko, a major provider of remote patient monitoring and digital health solutions for diabetes.

At LSX USA Congress 2025, Glooko CEO Mike Alvarez and Orthogonal CSO Randy Horton discussed the essential factors, including regulatory compliance, cross-functional collaboration, patient data protection, and strategic partnerships, needed to scale a digital health platform like Glooko across global markets.

Glooko, a leading provider of digital-health and remote-patient monitoring systems for diabetes, acquired Monarch Medical Technologies, adding an inpatient glucose-management system to its outpatient capabilities.

At the 2025 LSX World Congress USA in Boston, Glooko CEO Mike Alvarez discussed global expansion strategies, the real costs and risk, and importance of local partnerships for medtech companies, drawing on his experience.

The strategic acquisition of Monarch Medical Technologies allows Glooko to expand its connected care capabilities into inpatient glycemic management, complementing its existing strength in outpatient diabetes management.

Glooko has acquired Monarch Medical Technologies in a move that will expand the diabetes care company into inpatient glucose management.

Glooko announced its acquisition of Monarch Medical Technologies, marking the digital health company’s expansion into inpatient diabetes care.